Bumetanide Injection
Product Images NDC 0641-6284

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0641-6284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bumetanide Injection Usp Novaplus 1)

Chemical structure of Bumetanide showing the molecular arrangement with functional groups including carboxyl (COOH), sulfonamide (SO2NH2), and phenoxy (OC6H5) substituents on a benzene ring.*

FDA Label Image

Pi Black Ww Logo (Bumetanide Injection Usp Novaplus 2)

Bumetanide Injection, USP 1 mg per 4 mL (0.25 mg/mL) single-dose vial label by Hikma Pharmaceuticals USA Inc. The label specifies use for IV or IM injection and states the solution contains benzyl alcohol. It provides ingredients and storage information, including dosage strength and preservative details.*

FDA Label Image

4 mL Vial Container Label (Bumetanide Injection Usp Novaplus 3)

Bumetanide Injection, USP 0.25 mg/mL (1 mg per 4 mL) label for intravenous or intramuscular use. The label indicates the product is in 10 single-dose vials of 4 mL each, manufactured by Hikma Pharmaceuticals USA Inc. It includes key information such as preservative content (benzyl alcohol), storage instructions, and active ingredient concentration.*

FDA Label Image

10 X 4 mL Vial Shelfpack Label (Bumetanide Injection Usp Novaplus 4)

Label for Bumetanide Injection, USP, 2.5 mg per 10 mL (0.25 mg/mL) multi-dose vial by Hikma Pharmaceuticals USA Inc. The label indicates use for IV or IM administration and notes the product contains benzyl alcohol. Additional information includes inactive ingredients and storage instructions, with the product intended for prescription use only.*

FDA Label Image

462-706-00 10 mL Vial (Bumetanide Injection Usp Novaplus 5)

Bumetanide Injection, USP 0.25 mg/mL in a 10 mL multiple dose vial carton labeled for intravenous or intramuscular use. The label states 2.5 mg per 10 mL total concentration, includes preservative information, storage instructions, and manufacturer Hikma Pharmaceuticals USA Inc. The brand Novaplus is also visible.*

FDA Label Image

462-707-00 10 X 10 mL Vial Shelfpack (Bumetanide Injection Usp Novaplus 6)

Label panel featuring a QR code and various alphanumeric identifiers including GTIN, serial number, expiration date (EXP), and lot number (LOT). The product is Bumetanide, with available strength of 0.25 mg/mL, labeled by Hikma Pharmaceuticals USA Inc. This label panel is likely used for supply chain and product tracking purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.